DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 167 filers reported holding DIPLOMAT PHARMACY INC in Q3 2017. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $287,000 | -42.0% | 14,240 | -42.3% | 0.01% | -30.8% |
Q4 2017 | $495,000 | +0.2% | 24,687 | +3.5% | 0.01% | -7.1% |
Q3 2017 | $494,000 | +38.4% | 23,849 | -1.1% | 0.01% | +27.3% |
Q2 2017 | $357,000 | +6.2% | 24,117 | +14.4% | 0.01% | +10.0% |
Q1 2017 | $336,000 | +37.7% | 21,084 | +8.9% | 0.01% | +42.9% |
Q4 2016 | $244,000 | – | 19,356 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |